Read the Guest Post by Dr. Mary De Vera and Natasha Campbell of the UBC Faculty of Pharmaceutical Sciences.
In six previous Therapeutics Letters, we reported information about the benefits and harms of different proton pump inhibitors (PPIs).These drugs work by irreversibly inhibiting gastric H+K+ ATPase (the proton pump) in the stomach. They inhibit both basal and stimulated acid secretion and are used in a number of clinical settings: gastroesophageal reflux disease (GERD), reflux esophagitis, peptic ulcer disease (PUD), and symptoms associated with stomach acid such as heartburn and acid indigestion.
Read the guest post by consultant pharmacist Jennifer Dunkin and community pharmacist Lexi Shewchuk.
Read the guest post from Dr. David Gardner and Dr. Andrea Murphy from Dalhousie University.
Learn more about the College's 2015/16 Annual Report.
Learn more about CPSBC's new professional standard.
Read the guest post from UBC Pharmacy Residents Andrea Silver and Andrew Cobleigh.